US Broker Ratings

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 81% Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical pioneer based in Miami, Florida, has captured investor attention with an impressive potential upside of 81.28%. Specializing in the discovery, development, and commercialization..

BeOne Medicines Ltd. (ONC) Stock Analysis: Discovering a 28% Upside in the Biotech Sector

Investors eyeing the healthcare sector have a promising candidate in BeOne Medicines Ltd. (ONC), a biotechnology firm based in Switzerland, with a substantial market capitalization of $34.57 billion. Known for..

Sanofi (SNY) Investor Outlook: Exploring a 22.45% Upside in a Challenging Market

Sanofi (NYSE: SNY), a titan in the global healthcare sector, is a noteworthy player in the drug manufacturing industry. With a rich history dating back to its incorporation in 1994,..

Merck & Company, Inc. (MRK) Stock Analysis: Robust Dividend and Promising Upside for Investors

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to attract investor attention due to its significant market presence and robust financial performance. As a leader..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 12.57% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare sector specializing in diagnostics and research, is drawing attention from investors due to its robust market presence and promising upside..

Novo Nordisk A/S (NVO) Stock Analysis: Robust Revenue Growth and Attractive Dividend Yield

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to stand out with its strong financial performance and strategic focus on..

Medtronic plc (MDT) Stock Analysis: A 14.97% Potential Upside with Strong Dividend Appeal

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, continues to command investor attention with its sizable market presence and robust product portfolio. As a key player in..

Eli Lilly and Company (LLY) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Optimism

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its impressive market cap of $966.16 billion. This pharmaceutical giant, headquartered in..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a $406 Billion Healthcare Giant with a 6.39% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, stands out with its robust market capitalization of $406.46 billion. Known for its innovative contributions to biopharmaceuticals, AbbVie is a..

Danaher Corporation (DHR) Stock Analysis: Potential Upside and Analyst Ratings Highlight Investment Appeal

Danaher Corporation (NYSE: DHR), a prominent player in the Healthcare sector, particularly in the Diagnostics & Research industry, continues to capture investor interest with its robust growth potential and strong..

Abbott Laboratories (ABT) Stock Analysis: Exploring a 15.69% Potential Upside with Strong Buy Ratings

Abbott Laboratories (NYSE: ABT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. With a robust market capitalization of $217.28 billion, Abbott’s reach and..

Stryker Corporation (SYK) Stock Analysis: Evaluating a 20.86% Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is making waves in the medical devices industry with a robust market capitalization of $135.46 billion. As a key player..

Thermo Fisher Scientific Inc (TMO) Stock Report: Analyst Ratings Highlight 10% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a titan in the healthcare sector, continues to cement its position as a leader in the diagnostics and research industry. With a formidable market..

AstraZeneca PLC (AZN) Stock Analysis: A Promising 6.52% Upside Potential for Investors

AstraZeneca PLC (AZN) stands tall within the healthcare sector as a formidable player in the global pharmaceutical landscape. With a market capitalization of $288.04 billion, it is a giant in..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Glimpse at the 16.90% Return on Equity and Future Prospects

Intuitive Surgical, Inc. (NASDAQ: ISRG), with its robust market capitalization of $207.13 billion, has long been a stalwart in the healthcare sector, particularly within the medical instruments & supplies industry...

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 46.91% Potential Upside in the Healthcare Sector

AngioDynamics, Inc. (ANGO), a prominent player in the medical technology sector, is capturing the attention of investors with its promising growth potential and a substantial upside forecast. Trading at $13.16,..

MBX Biosciences, Inc. (MBX) Stock Analysis: Biotech’s 84% Upside Potential Beckons Investors

MBX Biosciences, Inc. (NASDAQ: MBX), a burgeoning player in the biotechnology sector, presents a compelling opportunity for investors with its cutting-edge focus on precision peptide therapies. Operating out of Carmel,..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Unveiling a 30% Potential Upside Amidst Industry Challenges

Investors with a keen interest in the healthcare sector, particularly in diagnostics and research, might find Myriad Genetics, Inc. (NASDAQ: MYGN) an intriguing candidate for their portfolios. With a market..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Upside and Risks in the Biotech Sector

Fortrea Holdings Inc. (FTRE) is a rising entity in the healthcare sector, specifically within the biotechnology industry. Headquartered in Durham, North Carolina, this contract research organization has made significant inroads..

Prothena Corporation plc (PRTA) Stock Analysis: Biotechnology Innovator with 109.84% Potential Upside

Prothena Corporation plc (NASDAQ: PRTA), a prominent player in the biotechnology sector, offers an intriguing investment opportunity given its substantial growth potential and innovative research pipeline. Based in Dublin, Ireland,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds